Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$112.05 USD
+5.73 (5.39%)
Updated Jun 7, 2024 04:00 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Jazz Pharmaceuticals PLC [JAZZ]
Reports for Purchase
Showing records 141 - 160 ( 249 total )
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
1Q18 Results: Big Beat, Conservative Raise; Reiterate Neutral and $160 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Updating Estimates Post Results and Guidance; Reiterate Neutral; Raise to $160 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Transferring Coverage; A Growth Company, but Execution and Xyrem Risk Remain; Assume With Neutral and $150 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O